not tagged
Poseida Therapeutics
['solid tumor', 'prostate', 'car t']
today we checked out tanya b. dorff, md at #asco22 who presented data from ongoing trials of psma-targeting (poseida-psma-101 trial) and psca-targeting car t cells for prostate cancer, challenges associated with use of adoptive cell therapy to treat solid tumors. 
Society for Immunotherapy of Cancer (SITC) - Dedicated to improving cancer patient outcomes by advancing the field of tumor immunology and cancer immunotherapy.